Access to affordable drugs is a real problem. We need to make drugs more affordable. But, using march-In rights to control drug prices is the wrong solution and would be catastrophic public policy. NIST’s[1] Proposed Rule Change (Clarification) In early January 2021, while most of us were still dealing with the pandemic, trying to…
On September 2, 2020, Russell E. Levine, JD, Kirkland & Ellis, presented an AUTM webinar entitled “Top 10 Court Decisions of the Year That Affect Licensing.” Russell, a past president of LES USA & Canada, has been doing these “top 10” talks for many years at LES annual meetings. These talks are always a full…
This workshop will focus on teaching you how to help investigators focus their technology disclosures, funding pitches, and other presentations on the three key factors crucial to gaining interest and commitment: commercial potential, technical merit and investigator willingness to assist.
As many academic institutions begin a new fiscal year, let’s take a moment to celebrate the end of an era in academic technology transfer (TT). The long and distinguished careers of TT luminaries have come to an end as they retire or transition to less demanding positions. In the past year or so, individuals who…
Our daughter, it seems, emerged from the womb negotiating; our son was more laid back. Today, she’s still at it (as are her 3 daughters) and our son has effectively learned when and how to negotiate for what he needs and wants. Becoming a skilled negotiator is achievable, regardless of personality type. Here are 10…